Ring Christine's Form 4 filing
Nurix Therapeutics, Inc. (NRIX) · filed Apr 30, 2025
- Accession no.
- 0001549595-25-000060
- Filed
- Apr 30, 2025
- Trade date
- Apr 30, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $33.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ring ChristineCIK 0001817199 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | Common Stock | MOption exerciseAcquired | +1,924 | $0.00 | $0 | 34,462 | Direct | |
| Apr 30, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $0.00 | $0 | 36,462 | Direct | |
| Apr 30, 2025 | Common Stock | MOption exerciseAcquired | +3,750 | $0.00 | $0 | 40,212 | Direct | |
| Apr 30, 2025 | Common Stock | SSaleDisposed | −2,894 | $11.50F2 | −$33,281 | 37,318 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | Common Stock | MOption exerciseDisposed | −1,924 | $0.00 | $0 | 5,773 | Direct | |
| Apr 30, 2025 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 8,000 | Direct | |
| Apr 30, 2025 | Common Stock | MOption exerciseDisposed | −3,750 | $0.00 | $0 | 30,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. The lowest price at which shares were sold was $11.05 and the highest price at which shares were sold was $11.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.